Q BioMed, Washington Univ. team up in glaucoma
Executive Summary
Washington University licensed Q BioMed Inc. an exclusive option to evaluate the growth differentiation factor 15 (GDF15) gene biomarker as a companion diagnostic with the MAN01 small molecule for glaucoma.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D (No Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice